United States · FDA National Drug Code directory
BONINE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 65197-275_7c66f984-240b-40dc-affd-9f1562f57c7c
- Product NDC
- 65197-275
- Form
- TABLET, CHEWABLE
- Composition / generic term
- meclizine hydrochloride
- Labeler
- WellSpring Pharmaceutical Corporation
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start / end (source format)
- 20141215 / 20261231
Source-listed ingredients
- MECLIZINE HYDROCHLORIDE — 25 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 2 TABLET, CHEWABLE in 1 POUCH (65197-275-02) · 65197-275-02
- 1 BLISTER PACK in 1 BOX (65197-275-08) / 8 TABLET, CHEWABLE in 1 BLISTER PACK · 65197-275-08
- 1 BOTTLE in 1 BOX (65197-275-12) / 12 TABLET, CHEWABLE in 1 BOTTLE · 65197-275-12
- 2 BLISTER PACK in 1 BOX (65197-275-16) / 8 TABLET, CHEWABLE in 1 BLISTER PACK · 65197-275-16
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →